NYSE · Biotech stocks database

ABT — Abbott Laboratories

ABT (Abbott Laboratories) stock: $102.61, $177.55B market cap, $5.10B cash, $202.09B EV, $182.02B fully diluted market cap. Next expected readout: Oct-26. Data from Fully Diluted's biotech stocks database.

Share price

$102.61

Market cap

$177,554.6M

Cash

$5,104.0M

Enterprise value

$202,088.6M

Balance sheet

Cash	$5,104.0M
Debt	$29,638.0M
Net cash	-$24,534.0M
Enterprise value	$202,088.6M
Basic shares	1,743.0M shares
Fully diluted shares	1,773.9M shares
Fully diluted market cap	$182,024.3M
Cash per share	$2.93

Cash figures as of 2026-06-30. Database snapshot: 2026-09-21.

Price history

Loading ABT daily closes…

Loading price history…

Upcoming catalysts

Expected	Drug	Phase	Indication	Mgmt guide
Aug 18 - Sep 29	Oral Anticoagulant, Direct-Acting	Phase 3	Cryptogenic Ischemic Stroke; Patent Foramen Ovale	—

Estimated readout windows: registry primary-completion date + 6-12 weeks. Windows already open are shown from "Now". Drug names link to ClinicalTrials.gov.

Full readout calendar →

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT06668935	Not disclosed	Recruiting	Sponsor	ABT	—	Diabetes Mellitus	—
NCT07421076	Not disclosed	Recruiting	Sponsor	ABT	—	Paroxysmal Atrial Fibrillation (PAF)	—
NCT06921902	Not disclosed	Recruiting	Sponsor	ABT	—	Pre Diabetes	—
NCT06436053	Not disclosed	Recruiting	Sponsor	ABT	—	Heart Failure	—
NCT04959552	Not disclosed	Active, not recruiting	Sponsor	ABT	—	Diabete Mellitus	—
NCT05061004	Not disclosed	Recruiting	Sponsor	ABT	—	Mitral Regurgitation	—
NCT07373353	Not disclosed	Recruiting	Sponsor	ABT	—	Ischemic Heart Disease (IHD)	—
NCT06595615	Not disclosed	Enrolling by invitation	Sponsor	ABT	—	Cardiac Disease	—
NCT07509658	Not disclosed	Recruiting	Sponsor	ABT	—	Tricuspid Regurgitation	—
NCT05932615	Not disclosed	Enrolling by invitation	Sponsor	ABT	—	Aortic Valve Stenosis; Heart Valve Diseases; Aortic Valve Disease	—
NCT06423430	Not disclosed	Recruiting	Sponsor	ABT	—	Treatment Resistant Depression	—
NCT07256925	Not disclosed	Recruiting	Sponsor	ABT	—	Malnutrition, Calorie; Sarcopenia	—

Sponsor-matched active trials from ClinicalTrials.gov (85 as sponsor, 100 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 185 active trials for Abbott Diabetes Care on ClinicalTrials.gov

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 714 stocks.

Subscribe to Compounding Ego